Top

Published in:

01-06-2014 | Research Article

TERT rs2736100 polymorphism contributes to lung cancer risk: a meta-analysis including 49,869 cases and 73,464 controls

Authors: Wei Nie, Yuansheng Zang, Jiquan Chen, Qingyu Xiu

Published in: Tumor Biology | Issue 6/2014

Abstract

Some studies investigated the association of TERT rs2736100 polymorphism with lung cancer (LC). But the results were not consistent. We performed a meta-analysis to examine the association between rs2736100 and LC. Databases including PubMed, EMBASE, Wanfang, and China National Knowledge Infrastructure (CNKI) were searched. Data were extracted, and pooled odds ratios (ORs) with 95 % confidence intervals (CIs) were calculated. A total of 19 studies including 49,869 cases and 73,464 controls were involved in this meta-analysis. Overall, a significant association between TERT rs2736100 polymorphism and LC risk was observed (OR = 1.23, 95 % CI 1.18–1.28, P < 0.00001). This polymorphism was also significantly associated with LC risk in Asians (OR = 1.27, 95 % CI 1.22–1.33, P < 0.00001), Caucasians (OR = 1.14, 95 % CI 1.10–1.18, P < 0.00001), female patients (OR = 1.37, 95 % CI 1.24–1.51, P < 0.00001), male patients (OR = 1.23, 95 % CI 1.15–1.31, P < 0.00001), adenocarcinoma patients (OR = 1.35, 95 % CI 1.28–1.41, P < 0.00001), squamous cell carcinoma patients (OR = 1.13, 95 % CI 1.04–1.21, P = 0.002), small cell lung cancer patients (OR = 1.09, 95 % CI 1.03–1.16, P = 0.004), current smokers (OR = 1.22, 95 % CI 1.17–1.27, P < 0.00001), former smokers (OR = 1.14, 95 % CI 1.08–1.21, P < 0.0001), and never smokers (OR = 1.37, 95 % CI 1.31–1.43, P < 0.00001), respectively. This meta-analysis suggested that TERT rs2736100 polymorphism was a risk factor for LC.

Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63:11–30.CrossRefPubMed

Strazisar M, Mlakar V, Glavac D. The expression of COX-2, hTERT, MDM2, LATS2 and S100A2 in different types of non-small cell lung cancer (NSCLC). Cell Mol Biol Lett. 2009;14:442–56.CrossRefPubMed

Zhu CQ, Cutz JC, Liu N, Lau D, Shepherd FA, Squire JA, et al. Amplification of telomerase (hTERT) gene is a poor prognostic marker in non-small-cell lung cancer. Br J Cancer. 2006;94:1452–9.PubMedCentralCrossRefPubMed

Hara H, Yamashita K, Shinada J, Yoshimura H, Kameya T. Clinicopathologic significance of telomerase activity and hTERT mRNA expression in non-small cell lung cancer. Lung Cancer. 2001;34:219–26.CrossRefPubMed

Xie M, Chen Q, He S, Li B, Hu C. Silencing of the human TERT gene by RNAi inhibits A549 lung adenocarcinoma cell growth in vitro and in vivo. Oncol Rep. 2011;26:1019–27.PubMed

McKay JD, Hung RJ, Gaborieau V, Boffetta P, Chabrier A, Byrnes G, et al. Lung cancer susceptibility locus at 5p15.33. Nat Genet. 2008;40:1404–6.PubMedCentralCrossRefPubMed

Jin G, Xu L, Shu Y, Tian T, Liang J, Xu Y, et al. Common genetic variants on 5p15.33 contribute to risk of lung adenocarcinoma in a Chinese population. Carcinogenesis. 2009;30:987–90.CrossRefPubMed

Landi MT, Chatterjee N, Yu K, Goldin LR, Goldstein AM, Rotunno M, et al. A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma. Am J Hum Genet. 2009;85:679–91.PubMedCentralCrossRefPubMed

Hsiung CA, Lan Q, Hong YC, Chen CJ, Hosgood HD, Chang IS, et al. The 5p15.33 locus is associated with risk of lung adenocarcinoma in never-smoking females in Asia. PLoS Genet. 2010;6:e1001051.PubMedCentralCrossRefPubMed

10.

Kohno T, Kunitoh H, Shimada Y, Shiraishi K, Ishii Y, Goto K, et al. Individuals susceptible to lung adenocarcinoma defined by combined HLA-DQA1 and TERT genotypes. Carcinogenesis. 2010;31:834–41.CrossRefPubMed

11.

Miki D, Kubo M, Takahashi A, Yoon KA, Kim J, Lee GK, et al. Variation in TP63 is associated with lung adenocarcinoma susceptibility in Japanese and Korean populations. Nat Genet. 2010;42:893–6.CrossRefPubMed

12.

Wang Y, Broderick P, Matakidou A, Eisen T, Houlston RS. Role of 5p15.33 (TERT-CLPTM1L), 6p21.33 and 15q25.1 (CHRNA5-CHRNA3) variation and lung cancer risk in never-smokers. Carcinogenesis. 2010;31:234–8.CrossRefPubMed

13.

Yoon KA, Park JH, Han J, Park S, Lee GK, Han JY, et al. A genome-wide association study reveals susceptibility variants for non-small cell lung cancer in the Korean population. Hum Mol Genet. 2010;19:4948–54.CrossRefPubMed

14.

Hu Z, Wu C, Shi Y, Guo H, Zhao X, Yin Z, et al. A genome-wide association study identifies two new lung cancer susceptibility loci at 13q12.12 and 22q12.2 in Han Chinese. Nat Genet. 2011;43:792–6.CrossRefPubMed

15.

Pande M, Spitz MR, Wu X, Gorlov IP, Chen WV, Amos CI. Novel genetic variants in the chromosome 5p15.33 region associate with lung cancer risk. Carcinogenesis. 2011;32:1493–9.PubMedCentralCrossRefPubMed

16.

Bae EY, Lee SY, Kang BK, Lee EJ, Choi YY, Kang HG, et al. Replication of results of genome-wide association studies on lung cancer susceptibility loci in a Korean population. Respirology. 2012;17:699–706.CrossRefPubMed

17.

Chen XF, Cai S, Chen QG, Ni ZH, Tang JH, Xu DW, et al. Multiple variants of TERT and CLPTM1L constitute risk factors for lung adenocarcinoma. Genet Mol Res. 2012;11:370–8.CrossRefPubMed

18.

Ito H, McKay JD, Hosono S, Hida T, Yatabe Y, Mitsudomi T, et al. Association between a genome-wide association study-identified locus and the risk of lung cancer in Japanese population. J Thorac Oncol. 2012;7:790–8.CrossRefPubMed

19.

Li H, Yang L, Zhao X, Wang J, Qian J, Chen H, et al. Prediction of lung cancer risk in a Chinese population using a multifactorial genetic model. BMC Med Genet. 2012;13:118.PubMedCentralCrossRefPubMed

20.

Shiraishi K, Kunitoh H, Daigo Y, Takahashi A, Goto K, Sakamoto H, et al. A genome-wide association study identifies two new susceptibility loci for lung adenocarcinoma in the Japanese population. Nat Genet. 2012;44:900–3.CrossRefPubMed

21.

Brenner DR, Brennan P, Boffetta P, Amos CI, Spitz MR, Chen C, et al. Hierarchical modeling identifies novel lung cancer susceptibility variants in inflammation pathways among 10,140 cases and 11,012 controls. Hum Genet. 2013;132:579–89.PubMedCentralCrossRefPubMed

22.

Lan Q, Cawthon R, Gao Y, Hu W, Hosgood 3rd HD, Barone-Adesi F, et al. Longer telomere length in peripheral white blood cells is associated with risk of lung cancer and the rs2736100 (CLPTM1L-TERT) polymorphism in a prospective cohort study among women in China. PLoS One. 2013;8:e59230.PubMedCentralCrossRefPubMed

23.

Myneni AA, Chang SC, Niu R, Liu L, Ochs-Balcom HM, Li Y, et al. Genetic polymorphisms of TERT and CLPTM1L and risk of lung cancer—a case-control study in a Chinese population. Lung Cancer. 2013;80:131–7.PubMedCentralCrossRefPubMed

24.

Spitz MR, Amos CI, Land S, Wu X, Dong Q, Wenzlaff AS, et al. Role of selected genetic variants in lung cancer risk in African Americans. J Thorac Oncol. 2013;8:391–7.PubMedCentralCrossRefPubMed

25.

Wang HM, Zhang XY, Jin B. TERT genetic polymorphism rs2736100 was associated with lung cancer: A meta-analysis based on 14,492 subjects. Genet Test Mol Biomarkers. 2013;17:937–41.PubMedCentralCrossRefPubMed

26.

Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–34.PubMedCentralCrossRefPubMed

27.

Lantuejoul S, Salon C, Soria JC, Brambilla E. Telomerase expression in lung preneoplasia and neoplasia. Int J Cancer. 2007;120:1835–41.CrossRefPubMed

28.

Fernandez-Garcia I, Ortiz-de-Solorzano C, Montuenga LM. Telomeres and telomerase in lung cancer. J Thorac Oncol. 2008;3:1085–8.CrossRefPubMed

29.

Blanco D, Vicent S, Fraga MF, Fernandez-Garcia I, Freire J, Lujambio A, et al. Molecular analysis of a multistep lung cancer model induced by chronic inflammation reveals epigenetic regulation of p16 and activation of the DNA damage response pathway. Neoplasia. 2007;9:840–52.PubMedCentralCrossRefPubMed

30.

Cha N, Li XY, Zhao YJ, Wang EH, Wu GP. hTERT gene amplification and clinical significance in pleural effusions of patients with lung cancer. Clin Lung Cancer. 2012;13:494–9.CrossRefPubMed

31.

Shen M, Cawthon R, Rothman N, Weinstein SJ, Virtamo J, Hosgood 3rd HD, et al. A prospective study of telomere length measured by monochrome multiplex quantitative PCR and risk of lung cancer. Lung Cancer. 2011;73:133–7.PubMedCentralCrossRefPubMed

Title: TERT rs2736100 polymorphism contributes to lung cancer risk: a meta-analysis including 49,869 cases and 73,464 controls
Authors: Wei Nie
Yuansheng Zang
Jiquan Chen
Qingyu Xiu
Publication date: 01-06-2014
Publisher: Springer Netherlands
Published in: Tumor Biology / Issue 6/2014
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI: https://doi.org/10.1007/s13277-014-1734-2

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 6/2014

Association between CLPTM1L-TERT rs401681 polymorphism and pancreatic cancer risk among Chinese Han population

Expression of targeted ribozyme against telomerase RNA causes altered expression of several other genes in tumor cells

The function of EMSY in cancer development

Association between MSH6 G39E polymorphism and cancer susceptibility: a meta-analysis of 7,046 cases and 34,554 controls

A systematic review of matrix metalloproteinase 9 as a biomarker of survival in patients with osteosarcoma

Estrogen receptor alpha gene polymorphisms and risk of prostate cancer: a meta-analysis involving 18 studies

Keynote webinar | Spotlight on antibody–drug conjugates in cancer